Arrow Intl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ARROW INTL, and what generic and branded alternatives to ARROW INTL drugs are available?
ARROW INTL has one approved drug.
Summary for Arrow Intl
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Arrow Intl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arrow Intl | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 201452-003 | May 21, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Arrow Intl | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 201452-006 | Mar 6, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Arrow Intl | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 201452-005 | Mar 6, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Arrow Intl | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 201452-002 | May 21, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
